Safety and Efficacy of Docetaxel, Darolutamide, and Homoharringtonine Combined With Androgen Deprivation Therapy in Neoadjuvant Treatment of High-Risk Prostate Cancer: A Multicenter Prospective, Single-Arm Clinical Study
Clinical trial NCT07516704 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07516704
- Sponsor
- Zhongda Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-01
- Primary completion
- 2027-12-01
- Enrollment
- 94
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.